Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions

Focused on Driving Margin Expansion

MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.

		Trois mois terminés le 30 septembre,											Neuf mois terminés le 30 septembre,
(En millions, sauf les données par action et les pourcentages)			2026				2025			Changer				2026				2025			Changer
Recettes		$	287.5			$	250.8			15	%		$	831.6			$	729.3			14	%
Marge brute			40.7	%			39.5	%						39.6	%			38.7	%
Résultat d'exploitation		$	20.8			$	7.9			NM			$	17.6			$	9.8			NM
Marge opérationnelle			7.2	%			3.1	%						2.1	%			1.3	%
Revenu net		$	20.3			$	7.5			171	%		$	27.1			$	17.8			52	%
Résultat par action diluée		$	0.47			$	0.18			161	%		$	0.63			$	0.42			50	%
Mesures non conformes aux PCGR*
Marge brute ajustée			41.0	%			39.8	%						39.9	%			39.2	%
EBITDA ajusté		$	51.5			$	37.0			39	%		$	135.2			$	101.2			34	%
Bénéfice par action dilué ajusté		$	0.61			$	0.35			74	%		$	1.49			$	0.96			55	%

*La marge brute ajustée, l'EBITDA ajusté et le bénéfice par action dilué ajusté comprennent des ajustements non conformes aux PCGR. Un tableau de rapprochement entre les indicateurs conformes aux PCGR et ceux non conformes aux PCGR est fourni dans le présent communiqué de presse sur les résultats.

NM - non significatif.

Management Comments
“We delivered our fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Our performance reflects the strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets. Strong demand for our differentiated welding and additive manufacturing solutions drove growth in Industrial Solutions while disciplined execution of our key strategic initiatives across defense and semiconductor markets led to strong growth in Advanced Solutions. Additionally, I anticipate that our acquisition of Lumibird Medical, which is expected to close in the fourth quarter, will further strengthen our reach, accelerate growth across medical markets, and increase revenue in Advanced Solutions.”

Faits saillants financiers

	Trois mois terminés le 30 septembre,									Neuf mois terminés le 30 septembre,
		2026			2025		Changer				2026			2025		Changer
Chiffre d'affaires par application
Solutions industrielles	$	239,548		$	214,697		12	%		$	704,181		$	607,593		16	%
Solutions avancées		47,952			36,095		33	%			127,396			121,713		5	%
Total	$	287,500		$	250,792		15	%		$	831,577		$	729,306		14	%

Third quarter revenue of $288 million increased 15% year over year, driven by 12% growth in Industrial Solutions and 33% growth in Advanced Solutions. Changes in foreign exchange rates increased revenue by approximately 1%. Industrial Solutions sales, accounting for 83% of total revenue, were driven by strong performance in welding and additive manufacturing applications. Advanced Solutions sales improved, driven by higher sales in semiconductor and defense applications. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter due to product mix. By region, sales increased 14% in Asia and 33% in North America and decreased 1% in Europe on a year-over-year basis.

GAAP gross margin of 40.7% and adjusted gross margin of 41.0% increased year over year, driven by lower product costs and $5.0 million in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption. Net income was $20 million, or $0.47 per diluted share, and adjusted EBITDA was $52 million and adjusted earnings per diluted share (EPS) was $0.61 in the third quarter. During the third quarter, IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures.

Perspectives d'activité et orientations financières

“Our third quarter book-to-bill was approximately one as we continued to see improved industrial demand and executed on our strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers. As we move forward, we remain focused on driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio,” concluded Dr. Gitin.

For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical.

As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 157 and Chinese yuan 6.74, respectively.

Informations financières complémentaires

Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Third Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.

Rappel de la conférence téléphonique

The Company will hold a conference call today, November 3, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.

Contact

Eugène Fedotoff
Directeur principal, Relations avec les investisseurs
IPG Photonics Corporation
508-597-4713
efedotoff@ipgphotonics.com

À propos d'IPG Photonics Corporation

Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.

Safe Harbor Statement
Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets, the expected timing of the closing of our acquisition of Lumibird Medical and the expectation that the acquisition will increase revenue in Advanced Solutions and strengthen our reach and accelerate growth across medical markets, strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers, driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio, revenue, adjusted gross margin and adjusted operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the fourth quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC for the fiscal year ended December 31, 2025), IPG's Quarterly Report on Form 10-Q (filed with the SEC for the quarter ended June 30, 2026), and other reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

 

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
		Trois mois terminés le 30 septembre,							Neuf mois terminés le 30 septembre,
			2026				2025			2026			2025
		(En milliers, sauf les données par action)
Chiffre d'affaires net		$	287,500			$	250,792		$	831,577		$	729,306
Coût des ventes			170,446				151,787			502,500			446,916
Marge brute			117,054				99,005			329,077			282,390
Dépenses d'exploitation :
Ventes et marketing			23,934				23,771			72,286			73,753
Recherche et développement			31,335				30,358			95,648			88,631
Frais généraux et administratifs			37,502				35,092			110,139			102,782
Règlement des litiges			-				-			13,334			-
Charges pour dépréciation			231				-			17,805			-
Charges de restructuration			-				425			-			425
Perte de change			3,275				1,504			2,293			7,013
Total des dépenses de fonctionnement			96,277				91,150			311,505			272,604
Résultat d'exploitation			20,777				7,855			17,572			9,786
Autres revenus, nets :
Revenus d'intérêts, nets			7,688				7,283			21,720			22,728
Other (expense) income, net			(50	)			516			2,683			2,026
Total des autres revenus			7,638				7,799			24,403			24,754
Résultat avant provision pour impôts sur les bénéfices			28,415				15,654			41,975			34,540
Provision pour impôts sur le revenu			8,142				8,191			14,876			16,714
Revenu net		$	20,273			$	7,463		$	27,099		$	17,826
Bénéfice net par action ordinaire :
De base		$	0.48			$	0.18		$	0.64		$	0.42
Dilué		$	0.47			$	0.18		$	0.63		$	0.42
Moyenne pondérée des actions ordinaires en circulation :
De base			42,531				42,199			42,416			42,427
Dilué			42,840				42,556			42,904			42,659

 

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
		30 septembre,				31 décembre,
			2026				2025
		(In thousands, except share data)
ACTIF
Actifs circulants :
Trésorerie et équivalents de trésorerie		$	710,688			$	403,790
Investissements à court terme			215,304				435,538
Créances, nettes			191,150				181,734
Inventaires			337,890				313,416
Impôts sur le revenu payés d'avance			33,145				43,196
Charges payées d'avance et autres actifs courants			54,460				45,766
Total de l'actif circulant			1,542,637				1,423,440
Placements à long terme			-				76,533
Impôts différés sur le revenu, nets			122,235				123,889
Goodwill			70,281				71,735
Immobilisations incorporelles, nettes			42,777				49,933
Immobilisations corporelles, nettes			648,326				637,516
Autres actifs			45,787				41,234
Total des actifs		$	2,472,043			$	2,424,280
PASSIF ET CAPITAUX PROPRES
Passif à court terme :
Comptes à payer		$	48,782			$	39,288
Charges à payer et autres passifs courants			204,874				184,849
Impôts sur le revenu à payer			3,858				9,900
Total des dettes à court terme			257,514				234,037
Autres passifs à long terme et impôts différés			59,581				62,113
Total du passif			317,095				296,150
Engagements et éventualités
Capitaux propres :
Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,380,668 and 42,508,140 shares issued and outstanding, respectively, at September 30, 2026; 56,964,939 and 42,127,067 shares issued and outstanding, respectively, at December 31, 2025.			6				6
Treasury stock, at cost, 14,872,528 and 14,837,872 shares held at September 30, 2026 and December 31, 2025, respectively.			(1,558,277	)			(1,555,629	)
Capital d'apport supplémentaire			1,097,673				1,077,172
Bénéfices non distribués			2,672,063				2,644,964
Cumul des autres éléments du résultat global			(56,517	)			(38,383	)
Total des capitaux propres			2,154,948				2,128,130
Total du passif et des capitaux propres		$	2,472,043			$	2,424,280

 

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
		Neuf mois terminés le 30 septembre,
			2026				2025
		(en milliers)
Flux de trésorerie provenant des activités d'exploitation :
Revenu net		$	27,099			$	17,826
Ajustements pour réconcilier le résultat net avec les liquidités nettes fournies par les activités d'exploitation :
Dépréciation et amortissement			47,377				46,799
Charges pour dépréciation			17,805				-
Provisions pour stocks, garanties et créances douteuses			33,594				31,766
Autres			25,081				21,119
Changes in assets and liabilities that provided (used) cash:
Comptes débiteurs et comptes créditeurs			1,535				18,787
Inventaires			(60,189	)			(52,005	)
Autres			(13,771	)			(37,757	)
Trésorerie nette provenant des activités d'exploitation			78,531				46,535
Flux de trésorerie provenant des activités d'investissement :
Achats et dépôts d'immobilisations corporelles			(54,437	)			(60,907	)
Produits de la vente d'immobilisations corporelles			2,204				605
Acquisitions de titres de placement			(360,732	)			(866,402	)
Purchases of equity investment			(8,000	)			-
Produits provenant de l'échéance de placements			663,124				633,731
Acompte versé par l'acheteur au titre des actifs destinés à la vente			2,000				-
Autres			111				69
Trésorerie nette provenant des (utilisée pour les) activités d'investissement			244,270				(292,904	)
Flux de trésorerie provenant des activités de financement :
Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option and purchase plans			(11,053	)			(4,316	)
Achat d'actions propres, net de la taxe d'accise, au coût d'acquisition			(2,648	)			(46,603	)
Trésorerie nette utilisée pour les activités de financement			(13,701	)			(50,919	)
Incidence des variations des taux de change sur la trésorerie, les équivalents de trésorerie et les actifs détenus en vue de la vente			(1,727	)			23,274
Net increase (decrease) in cash, cash equivalents and cash held for sale			307,373				(274,014	)
Trésorerie et équivalents de trésorerie - Début de la période			403,790				620,040
Trésorerie, équivalents de trésorerie et actifs détenus en vue de la vente — Fin de période		$	711,163			$	346,026
Informations supplémentaires sur les flux de trésorerie :
Liquidités versées au titre des intérêts		$	54			$	136
Paiements en espèces au titre de l'impôt sur le revenu, nets des remboursements		$	9,273			$	44,258
IPG PHOTONICS CORPORATION TABLEAU SUPPLEMENTAIRE DES MESURES FINANCIERES NON GAAP (NON VERIFIEES)

Utilisation d'informations financières ajustées non conformes aux PCGR

We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP.

We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges and amortization of acquisition-related intangibles.

Nous définissons la marge brute ajustée comme le résultat brut ajusté divisé par le chiffre d'affaires total.

We define adjusted operating expense and resultant adjusted operating income as reported operating expenses and resultant operating income, adjusted for non-recurring, infrequent, or unusual charges, including impairment charges, settlement and fees of litigation matters, restructuring charges, acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.

Nous définissons l'EBITDA comme le résultat net majoré des charges (ou produits) d'intérêts, de la provision pour impôts sur le résultat, des charges d'amortissement et des charges de dépréciation.

We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, restructuring charges, impairment charges, settlement and fees of litigation matters, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.

We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including impairment charges, settlement and fees of litigation matters, restructuring charges, amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.

Nous définissons le bénéfice par action ajusté comme le résultat net ajusté divisé par le nombre moyen pondéré d'actions en circulation après dilution.

Nous définissons le taux d'imposition ajusté comme le taux d'imposition selon les PCGR, corrigé des éléments fiscaux ponctuels et de l'impact net des ajustements hors PCGR.

La direction estime que ces indicateurs financiers non conformes aux PCGR constituent un outil supplémentaire pour évaluer la performance opérationnelle d'une période à l'autre. Plus précisément, ces indicateurs financiers non conformes aux PCGR offrent à la direction un moyen supplémentaire de comprendre et d'évaluer les résultats opérationnels et les tendances de nos activités courantes en excluant certaines charges hors trésorerie et d'autres éléments qui, selon la direction, pourraient autrement compliquer la comparaison de nos activités courantes avec les périodes précédentes, masquer les tendances des opérations courantes ou réduire la capacité de la direction à établir des prévisions utiles.

In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) amortization of acquisition-related intangibles, (ii) restructuring charges, (iii) acquisition and integration costs, (iv) impairment charges, (v) foreign exchange gains/losses, (vi) interest income, (vii) benefit (provision) from income taxes, (viii) depreciation, (ix) amortization, (x) stock-based compensation, (xi) gain/loss on disposal of assets/divestiture, (xii) settlement and fees of litigation matters, (xiii) certain discrete tax items, and (xiv) non-GAAP income tax reconciling adjustments.

Nous n'avons pas fourni de rapprochement quantitatif entre le bénéfice par action dilué ajusté non conforme aux PCGR et l'EBITDA ajusté, qui constituent des prévisions, et leurs mesures financières conformes aux PCGR les plus directement comparables, car nous ne sommes pas en mesure d'estimer avec une certitude raisonnable le moment ou le montant définitif de certains éléments significatifs sans déployer des efforts disproportionnés. Cela s'explique par la difficulté inhérente à prévoir le calendrier et/ou le montant de divers éléments susceptibles d'influencer le bénéfice ajusté par action dilué et l'EBITDA ajusté. Cela inclut des éléments qui ne se sont pas encore produits, qui échappent au contrôle de la Société, qui ne peuvent être raisonnablement prévus et/ou pour lesquels il n'y aurait pas d'ajustement ou de différence significative. Pour les mêmes raisons, la Société n'est pas en mesure d'évaluer l'importance probable des informations non disponibles.

Our non-GAAP tax provision for the fiscal third quarter of 2026 is 23%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.

IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASURES (UNAUDITED)
Rapprochement entre la marge brute et la marge brute ajustée, ainsi que la marge brute ajustée
		Trois mois terminés le 30 septembre,								Neuf mois terminés le 30 septembre,
			2026				2025				2026				2025
		(en milliers, sauf les pourcentages)
Marge brute		$	117,054			$	99,005			$	329,077			$	282,390
Marge brute			40.7	%			39.5	%			39.6	%			38.7	%
Amortissement des immobilisations incorporelles liées à l'acquisition			720				851				2,360				2,928
Frais liés aux acquisitions et à l'intégration			-				-				-				482
Marge brute ajustée		$	117,774			$	99,856			$	331,437			$	285,800
Marge brute ajustée			41.0	%			39.8	%			39.9	%			39.2	%

Reconciliation of Operating Expenses to Adjusted Operating Expenses

		Trois mois terminés le 30 septembre,						Neuf mois terminés le 30 septembre,
			2026			2025			2026			2025
		(en milliers)
Operating expenses		$	96,277		$	91,150		$	311,505		$	272,604
Less:
Amortissement des immobilisations incorporelles liées à l'acquisition			1,231			1,551			3,701			4,570
Frais liés aux acquisitions et à l'intégration			151			246			987			1,823
Charges pour dépréciation			231			-			17,805			-
Charges de restructuration			149			425			500			425
Règlement et frais liés aux litiges			-			-			14,435			-
Perte de change			3,275			1,504			2,293			7,013
Adjusted operating expenses		$	91,240		$	87,424		$	271,784		$	258,773

Reconciliation of Operating Income to Adjusted Operating Income

		Trois mois terminés le 30 septembre,						Neuf mois terminés le 30 septembre,
			2026			2025			2026			2025
		(en milliers)
Résultat d'exploitation		$	20,777		$	7,855		$	17,572		$	9,786
Amortissement des immobilisations incorporelles liées à l'acquisition			1,951			2,402			6,061			7,498
Frais liés aux acquisitions et à l'intégration			151			246			987			2,305
Charges pour dépréciation			231			-			17,805			-
Charges de restructuration			149			425			500			425
Règlement et frais liés aux litiges			-			-			14,435			-
Perte de change			3,275			1,504			2,293			7,013
Résultat d'exploitation ajusté		$	26,534		$	12,432		$	59,653		$	27,027

Rapprochement du résultat net et de l'EBITDA ajusté

		Trois mois terminés le 30 septembre,								Neuf mois terminés le 30 septembre,
			2026				2025				2026				2025
		(en milliers)
Revenu net		$	20,273			$	7,463			$	27,099			$	17,826
Revenus d'intérêts, nets			(7,688	)			(7,283	)			(21,720	)			(22,728	)
Provision pour impôts sur le revenu			8,142				8,191				14,876				16,714
Amortissement			12,986				12,392				38,447				36,120
Amortissement			2,976				3,240				8,930				10,679
EBITDA		$	36,689			$	24,003			$	67,632			$	58,611
Charges pour dépréciation			231				-				17,805				-
Rémunération en actions			11,022				10,780				31,597				32,834
Charges de restructuration			149				425				500				425
Frais liés aux acquisitions et à l'intégration			151				246				987				2,305
Règlement et frais liés aux litiges			-				-				14,435				-
Perte de change			3,275				1,504				2,293				7,013
EBITDA ajusté		$	51,517			$	36,958			$	135,249			$	101,188

Rapprochement entre le résultat net selon les PCGR et le résultat net hors PCGR, et entre le résultat net par action selon les PCGR et le résultat net par action dilué hors PCGR

		Trois mois terminés le 30 septembre,								Neuf mois terminés le 30 septembre,
			2026				2025				2026				2025
		(en milliers, sauf pour les données par action)
Revenu net		$	20,273			$	7,463			$	27,099			$	17,826
Charges pour dépréciation			231				-				17,805				-
Amortissement des immobilisations incorporelles liées à l'acquisition			1,951				2,402				6,061				7,498
Charges de restructuration			149				425				500				425
Frais liés aux acquisitions et à l'intégration			151				246				987				2,305
Règlement et frais liés aux litiges			-				-				14,435				-
Perte de change			3,275				1,504				2,293				7,013
Certains éléments fiscaux ponctuels			949				3,414				84				8,303
Incidence fiscale des ajustements non conformes aux PCGR			(711	)			(613	)			(5,337	)			(2,471	)
Résultat net ajusté		$	26,268			$	14,841			$	63,927			$	40,899
Bénéfice net ajusté par action diluée		$	0.61			$	0.35			$	1.49			$	0.96
Nombre moyen pondéré d'actions en circulation après dilution			42,840				42,556				42,904				42,659

Rapprochement entre le taux d'imposition conforme aux PCGR et le taux d'imposition non conforme aux PCGR

		Trois mois terminés le 30 septembre,								Neuf mois terminés le 30 septembre,
		2026				2025				2026				2025
Taux d'imposition		29		%		52		%		35		%		48		%
Éléments fiscaux ponctuels		(3	)	%		(22	)	%		-		%		(24	)	%
Impact net des ajustements non conformes aux PCGR		(3	)	%		(3	)	%		(11	)	%		(3	)	%
Taux d'imposition ajusté		23		%		27		%		24		%		21		%

 

 

Source : IPG Photonics Corporation IPG Photonics Corporation